ATH alterity therapeutics limited
Add to My Watchlist 0.00% ! 1.1¢

Donanemab approved in Australia for treatment of Alzheimer's disease

  1. HazASX
    9 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    22/05/25
    09:46
    Post #: 79143490
    ATH Price at posting: 1.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
NEWS High-Grade Assays Confirm Multiple Parallel Zones at Golden Eye
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS Sunshine Intersects Further Shallow High-Grade Gold at Liontown
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $60.81K 5.737M

Buyers (Bids)

No. Vol. Price($)
37 16255465 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1643984 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.